Stryker Corp
SYKNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 19/3020% below fair value
$306.81+14.95 (+5.12%)
Close on Nov 2, 2026Market cap $117.68BP/E 32.7Yield –
Stryker MedSurg & Neurotechnology by Quarter
MedSurg & Neurotechnology — Worldwide Constant Currency Growth YoY (%) (%)
Stryker MedSurg & Neurotechnology: 9.2% in Q3 2026.
Latest, Q3 2026
9.2%
Period ended Sep 30, 2026
Change on a year earlier
–
History
3 quarters
Since Q1 2026
Sources
3
Documents cited below
Where the Q3 2026 figure comes from
Reported in Stryker Form 8-K Supplemental Sales Schedules.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | MedSurg & Neurotechnology — Worldwide Constant Currency Growth YoY (%) (%) | Year on year | Source |
|---|---|---|---|---|
| Q3 2026 | Sep 30, 2026 | 9.2% | – | 0000310764-26-000059|sykex991earningsq32026.htm ↗ |
| Q2 2026 | Jun 30, 2026 | 9.2% | – | 0000310764-26-000048|sykex991earningsq22026.htm ↗ |
| Q1 2026 | Mar 31, 2026 | 3.6% | – | 0000310764-26-000025|sykex991earningsq12026.htm ↗ |
Cite this data
StockData. (2026). Stryker MedSurg & Neurotechnology (%), quarterly Q1 2026–Q3 2026 [Data set]. Compiled from Stryker SEC filings and investor materials. https://stockdatahq.com/stocks/syk/kpis/ms-tot-ww-cc
See every metric in the Stryker KPI table. Data updated Nov 2, 2026.